Trial intelligence / Profile preview

Advagraf vs Prograf in de Novo Liver Transplant Recipients

NCT01882322Phase 4Completed

Sponsor
Astellas Pharma
Start
Jan 2013
Primary completion
Jan 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Jan 2013; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT01882322.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01882322.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call